Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sofía Negro"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 13 (2022)
Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatme
Externí odkaz:
https://doaj.org/article/b8f3ae5f29b949b08bb8ed9be8ea6264
Autor:
Mario Alonso, Emilia Barcia, Juan-Francisco González, Consuelo Montejo, Luis García-García, Mónica-Carolina Villa-Hermosilla, Sofía Negro, Ana-Isabel Fraguas-Sánchez, Ana Fernández-Carballido
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2348 (2022)
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, with its incidence constantly increasing. To date, there is no cure for the disease, with a need for new and effective treatments. Morin hydrate (MH) is a naturally occurrin
Externí odkaz:
https://doaj.org/article/5ebda760940c4ae2ba6ade864ecfa257
Autor:
Damián Córdoba Díaz, Ana Isabel Fraguas Sánchez, Manuel Córdoba Díaz, Juan Aparicio-Blanco, Ana Fernandez-Carballido, Sofía Negro Álvarez, Emilia Barcia Hernández, Gonzalo D. García De Fernando Minguillón, Ana Isabel Torres Suárez, Cristina Martín Sabroso
Publikováno v:
Revista Iberoamericana de Tecnología en Educación y Educación en Tecnología, Iss 28 (2021)
Para llevar a cabo la virtualización, es importante adaptar la metodología a seguir, al objetivo, necesidades y contenido de la asignatura. Esto supone un reto a la hora de virtualizar prácticas de laboratorio en materias tecnológicas. Por ello s
Externí odkaz:
https://doaj.org/article/cddb0486391b43e4964f91356f24ba3e
Autor:
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani, Emilia Barcia
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1080 (2022)
To date there is no cure for Parkinson’s disease (PD), a devastating neurodegenerative disorder with levodopa being the cornerstone of its treatment. In early PD, levodopa provides a smooth clinical response, but after long-term therapy many patien
Externí odkaz:
https://doaj.org/article/d8ae4ccce34b42eaac719914e08fe282
Autor:
Emilia Barcia, Liudmila Boeva, Luis García-García, Karla Slowing, Ana Fernández-Carballido, Yaquelyn Casanova, Sofía Negro
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1112-1123 (2017)
A new drug delivery system is developed for ropinirole (RP) for the treatment of Parkinson’s disease (PD) consisting of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). The formulation selected was prepared with 8 mg RP and
Externí odkaz:
https://doaj.org/article/b7d65e48a86143449b9ce4899ac500a5
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 1, Pp 35-58 (2022)
Acta Pharmaceutica
Volume 72
Issue 1
Acta Pharmaceutica
Volume 72
Issue 1
Parkinson’s disease (PD) is the second most prevalent neuro-degenerative disease after Alzheimer´s disease. It is characterized by motor symptoms such as akinesia, bradykinesia, tremor, rigidity, and postural abnormalities, due to the loss of nigr
Autor:
Mario Alonso, Ana Fernández-Carballido, Emilia Barcia, Sofía Negro, Damián Cordoba-Diaz, Manuel Cordoba-Diaz
Publikováno v:
Current Pharmaceutical Analysis. 17:1178-1187
Background: Morin flavonoid exerts neuroprotective effects with potential interest in neurodegenerative disorders. For this, the use of surface-modified polymeric nanoparticles loaded with morin is an interesting approach. Objective: To develop and v
Autor:
Juan Aparicio-Blanco, Cristina Martín-Sabroso, Alexandre Pérez-López, Beatriz Tapias-Frutos, Sofía Negro-Álvarez, Damián Córdoba-Díaz, Ana Isabel Fraguas-Sánchez, Ana Fernández-Carballido, Emilia Barcia-Hernández, Sandra Catalán, Rafael Rodríguez-Sánchez, Ana Isabel Torres-Suárez
Publikováno v:
INTED2022 Proceedings.
Autor:
Sofía Negro Álvarez, Damián Córdoba Díaz, Ana Fernández Carballido, Emilia Barcia Hernández, Cristina Martín Sabroso, Ana Isabel Torres Suárez
Publikováno v:
INTED Proceedings.
Autor:
Yaquelyn Casanova, Liudmila Boeva, Ana Fernández-Carballido, Luis García-García, Sofía Negro, Emilia Barcia, Karla Slowing
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1112-1123 (2017)
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 1112-1123 (2017)
A new drug delivery system is developed for ropinirole (RP) for the treatment of Parkinson’s disease (PD) consisting of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). The formulation selected was prepared with 8 mg RP and